Global meningitis imaging market was valued at $164.70 thousand in 2020, and is projected to reach $243.72 thousand by 2030, registering a CAGR of 4.0% from 2021 to 2030. meningitis is an inflammation caused to brain and spinal cord.
It caused swelling of the brain which triggers the symptoms such as fever, headache and stiff neck. Meningitis includes some types such as bacterial meningitis, viral meningitis, fungal meningitis and others. In case of bacterial meningitis bacteria enter the blood stream and travel to the brain and cause bacterial meningitis. Ear and sinus infection is one of the major reason to get infected by bacterial meningitis. It includes bacteria such as streptococcus pneumonia, neisseria meningitides, and haemophilus influenza. Viral meningitis is usually shows mild symptoms. It includes the viruses like HIV mumps, herpes simplex virus and west nile virus. Fungal meningitis is also cause by person to person. It is life threatening if it is treated by at the right time.
Computed tomography is a major tool to detect the infection of meningitis. It is computerized x-ray imaging procedure in which it create detailed images of internal organs, soft tissue and blood vessels. In this procedure the cross-sectional images generated during computed tomography scan. Computer tomography scanning is the best method for detecting many different types of meningitis and the images allow doctors to identify the presence of infection associated with brain and spinal cord. It is also used to visualize the infection and evaluate injuries related to head, spine, heart, abdomen, and chest. It can diagnose a life threatening conditions. Whereas, magnetic resonance imaging (MRI) is also an effective imaging system. In addition, this diagnostic tools collectively known as neuroimaging. This neuroimaging can identify the situation that may predispose to bacterial meningitis. It is also used to monitor complications of meningitis such as empyema, hydrocephalus, and parenchymal abscess.
Growth of the global meningitis imaging market is majorly driven by increase in prevalence of meningitis disease; increase in various types of meningitis such bacterial meningitis, viral meningitis and fungal meningitis; increase in cases of tuberculosis which cause bacterial meningitis; rise in demand for magnetic resonance imaging , positron emission tomography and computed tomography scan to detect the infection; surge in usage of computed tomography scans to determine the efficacy of treatment; increase in development of new imaging system by large number of key players; and advancements in technologies in the field of imaging system.
According to Egyptian Journal of Radiology and Nuclear Medicine the value of contrast enhanced FLAIR magnetic resonance imaging (MRI) for detecting meningitis disease is an effective management and more reliable. It should be considered as the first line imaging modality in brain infections.
Magnetic resonance imaging is superior test in detecting extra-axial fluid collections due to lack of skull bony artifacts. Thus, rise in burden of meningitis, the demand for magnetic resonance imaging scan to diagnosis, anticipated the growth of the meningitis imaging market. Furthermore, rise in geriatric population, surge in demand to identify efficacy of the treatment, these factors fuel the growth of the meningitis imaging market. For instance, in December 2020, United Imaging launched uCT ATLAS an ultra-wide bore computed tomography system with innovative artificial intelligence technology designed to control pandemic. Thus, increase in awareness among people the use of computed tomography imaging for meningitis fuels the market growth. In March 2021, Nikon Corporation launched a new 225 kV, micro-focus X-ray CT system. This provides both interior and exterior sample to be calculated and examined non-destructively.
In addition, increase in number of manufacturers of imaging system, anticipate the growth of the market. For instance, in December 2020, Waygate Technologies ,a Baker Hughes business the world leader has launched its first high-energy computed tomography (CT) system, the Phoenix Power scan HE. Furthermore, rise in awareness among individuals for early diagnosis and management of meningitis, increase in number of products approvals is expected to provide remunerative opportunities for the expansion of the global meningitis imaging market during the forecast period.
The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global meningitis imaging market. At the starting of July 2020, a few cases have reported as an infection of meningitis with covid-19 at the same time. In that case computer tomography and magnetic resonance imaging are the most effective tools being used to identify the infection and to monitor the efficacy of the treatment. Implementing appropriate preventative safety measures, optimizing chest CT protocols, and developing a consistent reporting system based on pulmonary findings in this condition had improved the clinical value of CT. Thus rise in number of Covid-19 cases rise the usage of computed tomography scan is anticipated to drive the meningitis imaging market in the forecast period.
Thus, technological advancements in diagnostic instrument and rise in awareness regarding early diagnosis propel the growth of the market. However, high cost associated with imaging systems installation and maintenance is expected to restrict the market growth during the forecast period.
Meningitis Imaging Market Segmentation
The global meningitis imaging market is segmented into product type, disease type, end user and region. By product type, the market is categorized into magnetic resonance imaging, computed tomography and positron emission tomography.
On the basis of disease type, it is divided into bacterial meningitis, viral meningitis, fungal meningitis, and others. Depending on end user, it is categorized into hospitals & Clinic, and diagnostic centers.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Latin America and Middle East & Africa).
Depending on product type, the computed tomography segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for early detection, and surge in adoption of computed tomography systems. However, the magnetic resonance imaging segment is expected to witness considerable growth during the forecast period, owing to increase in number of diagnostic centers and increase in number of key players for development of computed tomography systems in the medical device industry.
By Product Type
Computed Tomography segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
By disease type, the viral meningitis segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in prevalence of meningitis, rise in consumption of contaminated food and increasing demand for early diagnostic. However, the bacterial meningitis segment is expected to witness considerable growth during the forecast period, due to increase in number of covid-19 cases cause meningitis, rise in demand for early diagnosis, and development of advanced computed tomography and magnetic resonance imaging systems in the hospital and clinics.
On the basis of end user, the hospitals & clinic segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to large number key players offering advanced magnetic resonance imaging, positron emission tomography and computed tomography devices, increase in demand to determine efficacy of treatments, development of novel & innovative imaging systems and advancement in R&D activities for diagnosis of various diseases. However, the diagnostic centers segment is expected to witness considerable growth during the forecast period, owing to increase in use the detection of cerebrovascular diseases which can lead can lead to stroke, or even death, surge in awareness about CT and MRI scan.
By End User
Hospitals & Clinics segment is projected as one of the most lucrative segment.
North America garnered the major share in the meningitis imaging market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of inflammatory diseases, presence of key players, development of the healthcare sector, presence of new innovative imaging systems, and advancement in technology for computed tomography in the region. However, Asia-Pacific is expected to register the highest CAGR of 4.2% from 2021 to 2030, owing to increase in prevalence of meningitis, rise in demand for early diagnosis, development of healthcare infrastructure.
The key players operating in the global meningitis imaging market include Accuray Incorporated, Canon Medical Systems Corporation, Fujifim Holdings Corporation, GE Healthcare, Koninklijke Philips N.V, Neusoft Medical Systems, Positron Corporation, Samsung Electronics Co.Ltd., Shimadzu Corporation, and Siemens AG.
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 4.2% during the forecast period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the meningitis imaging market, and the current trends & future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Meningitis Imaging Market Report Highlights
By DISEASE TYPE
By END USER
Key Market Players
ACCURAY INCORPORATED, FUJIFILM HOLDING CORPORATION, CANON MEDICAL SYSTEMS CORPORATION (CANON INC.), KONINKLIJKE PHILIPS NV, SAMSUNG ELECTRONICS CO.LTD, NEUSOFT MEDICAL SYSTEMS CO. LTD., POSITRON CORPORATION, SEIMENS AG, GE HEALTHCARE, SHIMADZU CORPORATION
Increasing prevalence of meningitis disease, increase in incidences of bacterial infection, shift of medical care toward image-guided interventions, and technological advancements are all attributed for growth of the meningitis imaging market. Greater consumer awareness and demand for preventive diagnostic screening, escalating demand for healthcare services from overall population and new technical advancements are predicted to broaden clinical applications of diagnostic imaging technology and increase the number of scans conducted.
In addition, increased participation of governments to control the outbreaks of meningitis is expected to drive the market. Furthermore, emphasis on less invasive procedures for diagnosis, as well as growing popularity of automated workflow in emergency clinical settings, contributes toward growth of the market.
The market gains interest of healthcare companies to launch a various types of imaging systems, owing to focus on preventive diagnosis and early detection of diseases. Highly advanced CT scanners, and MRI scan providing 3D images virtually in any patient, for those who have brain and spinal cord disorders, which are more complex than other health conditions. This leads to increase in utilization of imaging tools to identify meningitis infection, thus is a great opportunity for further propelling growth of the market.
North America is expected to witness highest growth, in terms of revenue, owing to rise in meningitis in newborn babies and children under the age of 5 years, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in incidences of chronic diseases, unmet needs for advanced diagnostic systems, and increasing awareness for preventive diagnosis in the healthcare sector. However, high cost of implementation, maintenance, and stringent government policies restrain the market growth.